Why UChicago business students are learning about global health
Apr 9, 2021 Booth course and initiative foster interdisciplinary collaboration with UChicago Medicine
We often think of global health as something vast, but Prof. Olufunmilayo Olopade wants us to realize that impacting global health can be a local endeavor.
“We need to create new models for reaching the unreached: It doesn’t matter where they are,” she said.
This is one of the forces that guides Olopade’s work from her entrepreneurship, to the new class she launched with her husband, Prof. Christopher Sola Olopade. The two University of Chicago physicians realized that many health care scenarios can benefit from someone with business acumen, while most entrepreneurs lack connections to medical expertise.
Published: Feb 19, 2021 By Alex Keown
PICI – Bristol Myers Squibb veteran Ute Dugan was named Senior Vice President of Clinical Research at the Parker Institute for Cancer Immunotherapy (PICI). She will oversee PICI’s clinical development, regulatory affairs and translational medicine efforts, with a focus on overcoming immunotherapy resistance and advancing novel breakthrough treatment combinations. At BMS, she was head of Worldwide Oncology External Medical Affairs, where she created research collaboration models to advance immune-oncology treatments together with partners in academia, professional societies and non-profit organizations. Dugan originally joined BMS as executive director of Global Clinical Research during the formation of the development teams for the pioneering I-O medicines ipilimumab and nivolumab. Before that, her career included stints at Roche/Genentech and Aventis.